This APOE ε4 effect was confirmed in a recent study from the same cohort that included a larger sample size (675 mutation carriers and 594 controls), and further reported that the APOE ε2 genotype was associated with a delay in age-dependent cognitive decline as compared to non-carriers [190]. The gene discussed is APOE; the disease is Mental deterioration.